Synapse - Hematologic Malignancies, Division of

Results (13379)

Capturing uveal melanoma (UM) global practice patterns and clinical outcomes in the collaborative ocular melanoma natural history (OMNi) study (NCT04588662)

Meeting Abstract

Sacco, J. J.; Orloff, M. M.; Patel, S. P.; Conway, M.; Lim, L. A.; Fog, L. S.; Sia, D.; McKenzie, J.; McKay, D.; O'Day, R.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A first-in-human phase 1 study of oral LOXO-338, a selective BCL2 inhibitor, in patients with advanced hematologic malignancies (trial in progress)

Meeting Abstract

Roeker, L. E.; Alencar, A. J.; Murthy, G. S. G.; Hoffmann, M. S.; Pagel, J. M.; Patel, V.; Pauff, J. M.; Zinzani, P. L.; Le Gouill, S.; Mato, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS)

Meeting Abstract

Rosenbaum, E.; Qin, L. X.; Thornton, K. A.; Movva, S.; Nacev, B. A.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Avutu, V.; Chi, P.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Efficacy and safety results from ASCEMBL, a phase 3 study of asciminib versus bosutinib (BOS) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) after ≥2 prior tyrosine kinase inhibitors (TKIs): Week 96 update

Meeting Abstract

Rea, D.; Mauro, M. J.; Hochhaus, A.; Boquimpani, C.; Lomaia, E.; Voloshin, S.; Turkina, A. G.; Kim, D. W.; Apperley, J.; Cortes, J. E.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

An open-label, multicenter, phase 1b/2 study of navtemadlin (KRT-232) in patients with relapsed/refractory acute myeloid leukemia secondary to myeloproliferative neoplasms

Meeting Abstract

Rampal, R.; Ramanathan, S.; Papayannidis, C.; von Bubnoff, N.; Díaz, M. D. T.; Vidriales, M. B.; Burguera, A. D. L. F.; Masarova, L.; Al-Ali, H. K.; Lavie, D.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib plus dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC)

Meeting Abstract

Randall, L. M.; O'Malley, D. M.; Monk, B. J.; Coleman, R. L.; Gaillard, S.; Adams, S. F.; Duska, L. R.; Cappuccini, F.; Dalton, H.; Holloway, R. W.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Overall survival (OS) in metastatic uveal melanoma: A summary of recent prospective trials

Meeting Abstract

Piulats, J. M.; Shoushtari, A. N.; Ochsenreither, S.; Abdullah, S. E.; Holland, C.; McCully, M. L.; Baurain, J. F.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

A phase 1b study to evaluate safety, tolerability, pharmacokinetics, and efficacy of SER-155 in adults undergoing hematopoietic stem cell transplantation to reduce the risk of infection and graft versus host disease (NCT04995653)

Meeting Abstract

Ponce, D. M.; Lombardo, M. J.; Ford, C. B.; Peled, J. U.; Van Den Brink, M. R. M.; Tejura, B.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including diffuse large B-cell lymphoma (DLBCL)

Meeting Abstract

Patel, K.; Sano, D.; Maris, M.; Lesokhin, A. M.; Von Keudell, G.; Doucette, K.; Ramchandren, R.; Pavlov, D.; Uger, R. A.; Molloy, N.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

TTI-622-01: A phase 1a/1b dose-escalation and expansion trial of TTI-622 in patients with advanced hematologic malignancies, including multiple myeloma

Meeting Abstract

Patel, K.; Orlowski, R. Z.; Doucette, K.; Maris, M.; Pianko, M. J.; Ramchandren, R.; Stevens, D. A.; Vesole, D. H.; Uger, R. A.; Scheuber, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save